Literature DB >> 29054214

Robotic-Assisted, Video-Assisted Thoracoscopic and Open Lobectomy: Propensity-Matched Analysis of Recent Premier Data.

Daniel S Oh1, Rishindra M Reddy2, Madhu Lalitha Gorrepati3, Shilpa Mehendale3, Michael F Reed4.   

Abstract

BACKGROUND: Robotic-assisted lobectomy (RL) is becoming a popular alternative technique to video-assisted thoracoscopic lobectomy (VL), although open lobectomy (OL) remains the most common approach. The objective of this study is to provide a comparative analysis of perioperative clinical outcomes from elective RL, VL, and OL.
METHODS: The Premier Healthcare Database was analyzed for lobectomies performed from January 1, 2011, to September 30, 2015. International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis and procedure codes were used to identify surgical approaches, complications, and mortality. Propensity score matching (1:1) for patient and hospital characteristics allowed comparison of RL versus OL (n = 2,775 each) and RL versus VL (n = 2,951 each).
RESULTS: Compared with OL in propensity matched analysis, RL was associated with a lower postoperative complication rate (p < 0.0001), shorter hospital stay (p < 0.0001), and lower mortality rate (p = 0.0282). Patients in the RL group were more likely to be discharged home than to a transitional health care facility (p < 0.0001). Compared with VL, the RL group had a lower conversion rate to thoracotomy (p < 0.0001), lower overall postoperative complication rate (p = 0.0061), and shorter hospital stay (p = 0.006). The RL patients also were more likely to be discharged home than to a transitional health care facility (p = 0.0108). The postoperative mortality rates of RL and VL were similar (p = 0.44). There was no difference in iatrogenic injuries when comparing RL with OL and RL with VL (p = 0.1284 and p = 0.5477, respectively).
CONCLUSIONS: Robotic-assisted lobectomy was associated with improved outcomes for certain perioperative clinical variables, including shorter length of stay and lower complication rates. It was also was associated with a lower conversion rate to OL compared with VL.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29054214     DOI: 10.1016/j.athoracsur.2017.06.020

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  38 in total

1.  The association of nodal upstaging with surgical approach and its impact on long-term survival after resection of non-small-cell lung cancer.

Authors:  Mark W Hennon; Luke H DeGraaff; Adrienne Groman; Todd L Demmy; Sai Yendamuri
Journal:  Eur J Cardiothorac Surg       Date:  2020-05-01       Impact factor: 4.191

2.  Subxiphoid or subcostal uniportal robotic-assisted surgery: early experimental experience.

Authors:  Diego Gonzalez-Rivas; Mahmoud Ismail
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

Review 3.  Updates on Minimally Invasive Surgery in Non-Small Cell Lung Cancer.

Authors:  Norihiko Ikeda
Journal:  Curr Treat Options Oncol       Date:  2019-02-11

4.  Robotic lobectomy leads to excellent survival in lung cancer patients.

Authors:  Min P Kim
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

5.  From "open" to robotic assisted thoracic surgery: why RATS and not VATS?

Authors:  Sara Ricciardi; Federico Davini; Carmelina Cristina Zirafa; Franca Melfi
Journal:  J Vis Surg       Date:  2018-05-22

6.  Stereotactic body radiotherapy for operable, early stage non-small cell lung cancer-let's all take a deep breath.

Authors:  Eric B Howell; Kathleen S Berfield; Douglas E Wood
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 7.  [Video-assisted thoracic surgery : A global development].

Authors:  G Leschber
Journal:  Chirurg       Date:  2018-03       Impact factor: 0.955

8.  Robotic-assisted thoracic surgery versus uniportal video-assisted thoracic surgery: is it a draw?

Authors:  Sara Ricciardi; Carmelina Cristina Zirafa; Federico Davini; Franca Melfi
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 9.  New Surgical Approaches in the Treatment of Non-Small Cell Lung Cancer.

Authors:  Giye Choe; Rebecca Carr; Daniela Molena
Journal:  Clin Chest Med       Date:  2020-04-16       Impact factor: 2.878

10.  Oropharyngeal and nasopharyngeal decontamination with chlorhexidine gluconate in lung cancer surgery: a randomized clinical trial.

Authors:  Xavier Benoit D'Journo; Pierre-Emmanuel Falcoz; Marco Alifano; Jean-Philippe Le Rochais; Thomas D'Annoville; Gilbert Massard; Jean Francois Regnard; Philippe Icard; Charles Marty-Ane; Delphine Trousse; Christophe Doddoli; Bastien Orsini; Sophie Edouard; Matthieu Million; Nathalie Lesavre; Anderson Loundou; Karine Baumstarck; Florence Peyron; Stephane Honoré; Stéphanie Dizier; Aude Charvet; Marc Leone; Didier Raoult; Laurent Papazian; Pascal Alexandre Thomas
Journal:  Intensive Care Med       Date:  2018-04-18       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.